GlassScriptPhysician profile
Dan Inder S Sraow
NPI 1588839419
$14,906.90
in general payments reported to CMS, 2019-2025
33 companies · $8,384 in 2025
The $8,384 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $342 · 2021: $339 · 2022: $466 · 2023: $1,569 · 2024: $2,582 · 2025: $8,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,688 · Food and Beverage: $4,481 · Travel and Lodging: $2,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,687.50 |
| Food and Beverage | $4,481.00 |
| Travel and Lodging | $2,366.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,003.12 | 2020-2025 | General - Therapies, General - Vascular Intervention, Eluvia |
| Abiomed | $1,785.00 | 2019-2025 | Impella |
| Heartflow, INC. | $516.36 | 2022-2024 | Ffrct |
| Philips North America LLC | $461.09 | 2019-2025 | Visions 014 |
| Abbott Laboratories | $453.70 | 2019-2023 | Cardiomems |
| Medtronic, INC. | $336.70 | 2021-2025 | Corevalve Evolut R, Ffrangio, Resolute Onyx |
| Edwards Lifesciences Corporation | $323.99 | 2020-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $315.93 | 2019-2025 | |
| Spinefrontier, INC. | $183.53 | 2025 | Inspan, Nanofuse, Facetfuse |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.34 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $137.25 | 2025 | Carto 3 |
| Nalu Medical, INC. | $132.12 | 2021 | |
| Baxter Healthcare | $116.23 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic Vascular, INC. | $103.05 | 2019-2020 | |
| Covidien LP | $103.05 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $101.03 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $75.96 | 2019-2024 | Wainua |
| Cardiva Medical, INC. | $69.50 | 2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Kestra Medical Technology Services, INC. | $67.50 | 2024-2025 | Assure Wcd |
| Shockwave Medical, INC | $59.61 | 2021 | |
| Amgen INC. | $49.68 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.93 | 2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $41.11 | 2020-2022 | |
| Cordis US Corp. | $37.68 | 2023 | Mynx Control, Radial 360 |
| Impulse Dynamics (USA) INC. | $36.90 | 2022-2023 | Optimizer |
| Stryker Corporation | $36.20 | 2025 | Limflow System |
| Cleerly, INC. | $30.30 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Chiesi USA, INC. | $30.13 | 2019 | |
| Scpharmaceuticals INC. | $17.10 | 2024 | |
| Medtronic USA, INC. | $16.36 | 2020 | |
| Merck Sharp & Dohme LLC | $16.12 | 2022 | |
| Pfizer INC. | $14.73 | 2025 | |
| Biotronik INC. | $14.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Inder Sraow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.